NISHA DESHPANDE: Open Payments
NPI 1154322147 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$585 in 26 payments from 13 companies in 2025. Trend: 2023 $644 · 2024 $83 · 2025 $585
Food & beverage: $585
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $132 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 5 | $111 |
| ABBVIE INC. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: JARDIANCE, AIRSUPRA, CAPLYTA, Ozempic, QULIPTA, FARXIGA, ZENPEP, Kerendia.
Industry payments across WI — which companies pay providers there.
